For­mer Al­ler­gan ex­ec heads to Re­vance as it chal­lenges Botox; Mark Pruzan­s­ki sur­rounds him­self with more team­mates

Re­vance feels like it has a com­pet­i­tive ad­van­tage over Ab­b­Vie’s block­buster Botox with on­ly bian­nu­al in­jec­tions of its fresh­ly ap­proved Daxxi­fy, as op­posed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.